A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma

被引:25
|
作者
Khurana, Vinod K. [1 ,2 ]
Misri, Rachita R. [1 ,2 ]
Agarwal, Swati [1 ,2 ]
Thole, Akhilesh V. [1 ,2 ]
Kumar, Sachin [1 ,2 ]
Anand, Tanu [3 ]
机构
[1] Hindu Rao Hosp, Dept Dermatol, New Delhi, India
[2] Hindu Rao Hosp, Dept Venereol & Leprosy, New Delhi, India
[3] Hindu Rao Hosp, Dept Prevent & Social Med, New Delhi, India
关键词
Clinical trials preparation; melasma; therapeutic studies; tranexamic acid; TRANS-4-AMINOMETHYLCYCLOHEXANECARBOXYLIC ACID;
D O I
10.4103/ijdvl.IJDVL_801_16
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Melasma poses a great challenge as its treatment modalities are unsatisfactory. Treatment using tranexamic acid is a novel concept. Aim: This study aimed to compare the therapeutic efficacy and safety of oral tranexamic acid and tranexamic acid microinjections in patients with melasma. Methods: This is a prospective, randomized, open-label study with a sample size of 64, 32 in each treatment arm. Thirty-two patients were administered localized microinjections (4 mg/ml) of tranexamic acid monthly in 1 arm, while in the other arm, 32 were given oral tranexamic acid 250 mg twice a day. Patients were followed up for 3 consecutive months. Clinical photographs were taken at each visit, and a modified melasma area and severity index scoring was performed at the beginning and end of treatment. Results: Improvement in melasma area and severity index score in the oral group was 57.5% as compared to 43.5% in the intralesional group. All 32 patients in the oral group (100%) showed >50% improvement, out of which 8 showed >75% improvement. In the intralesional group, 17 (53%) patients had >50% improvement, of which 3 had >75% improvement. The remaining 15 patients in this group had <50% improvement. Thus, the oral group showed a more significant response as compared to the intralesional group. No major adverse effects were observed in both the groups. At 6-month follow-up, two patients (6.2%) in the oral group had recurrence as compared to three patients (9.4%) in the intralesional group. Limitations: A small sample size was one of the limitations in this study. The dose of tranexamic acid in microinjections and the frequency of injections could have been increased. Conclusion: Tranexamic acid provides rapid and sustained improvement in the treatment of melasma. It is easily available and affordable. Oral route is undoubtedly efficacious, but the results of microinjections, while encouraging, can probably be enhanced by either increasing the frequency of injections or increasing the concentration of the preparation.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 50 条
  • [41] Oral tranexamic acid in the treatment of hyperpigmentation disorder beyond melasma: A review
    Mahjoub, Taghreed Tariq
    Milibary, Heba Hamza
    JOURNAL OF COSMETIC DERMATOLOGY, 2023, 22 (04) : 1157 - 1162
  • [42] Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study
    Chen-Yu Zhu
    Yun Li
    Qiu-Ning Sun
    Ayaka Takada
    Akira Kawada
    European Journal of Dermatology, 2019, 29 : 55 - 58
  • [43] Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma
    Botsali, Aysenur
    Esme, Pelin
    Erbil, Hakan
    Caliskan, Ercan
    LASERS IN MEDICAL SCIENCE, 2022, 37 (07) : 2823 - 2830
  • [44] Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study
    Zhu, Chen-Yu
    Li, Yun
    Sun, Qiu-Ning
    Takada, Ayaka
    Kawada, Akira
    EUROPEAN JOURNAL OF DERMATOLOGY, 2019, 29 (01) : 55 - 58
  • [45] Use of topical tranexamic acid in patients with melasma: A narrative review
    Thieman, Taylor
    Swali, Ritu
    Adams, Jennifer
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB126 - AB126
  • [46] Tranexamic Acid in the Treatment of Melasma: A Review of the Literature
    Marina Perper
    Ariel Eva Eber
    Rachel Fayne
    Sebastian Hugo Verne
    Robert James Magno
    Jessica Cervantes
    Mana ALharbi
    Ibrahim ALOmair
    Abdulkarem Alfuraih
    Keyvan Nouri
    American Journal of Clinical Dermatology, 2017, 18 : 373 - 381
  • [47] Topical tranexamic acid as a promising treatment for melasma
    Ebrahimi, Bahareh
    Naeini, Farahnaz Fatemi
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (08): : 753 - 757
  • [48] Tranexamic Acid in the Treatment of Melasma: A Review of the Literature
    Perper, Marina
    Eber, Ariel Eva
    Fayne, Rachel
    Verne, Sebastian Hugo
    Magno, Robert James
    Cervantes, Jessica
    ALharbi, Mana
    ALOmair, Ibrahim
    Alfuraih, Abdulkarem
    Nouri, Keyvan
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2017, 18 (03) : 373 - 381
  • [49] Efficacy of intradermal injection of tranexamic acid and ascorbic acid versus tranexamic acid and placebo in the treatment of melasma: A split-face comparative trial
    Pazyar, Nader
    Molavi, Seyedeh Nasrin
    Hosseinpour, Parisa
    Hadibarhaghtalab, Maryam
    Parvar, Seyedeh Yasamin
    Dezfuly, Motahareh Babazadeh
    HEALTH SCIENCE REPORTS, 2022, 5 (02)
  • [50] Tranexamic acid laser combination therapy in melasma
    Lorenz, Judith
    AKTUELLE DERMATOLOGIE, 2023, 49 (07) : 294 - 294